10x Genomics (TXG) Cost of Revenue (2018 - 2025)
Historic Cost of Revenue for 10x Genomics (TXG) over the last 8 years, with Q4 2025 value amounting to $53.0 million.
- 10x Genomics' Cost of Revenue fell 199.94% to $53.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $198.9 million, marking a year-over-year increase of 134.44%. This contributed to the annual value of $198.9 million for FY2025, which is 134.44% up from last year.
- Latest data reveals that 10x Genomics reported Cost of Revenue of $53.0 million as of Q4 2025, which was down 199.94% from $48.7 million recorded in Q3 2025.
- 10x Genomics' Cost of Revenue's 5-year high stood at $68.2 million during Q4 2023, with a 5-year trough of $4.9 million in Q2 2021.
- In the last 5 years, 10x Genomics' Cost of Revenue had a median value of $46.2 million in 2023 and averaged $40.0 million.
- Per our database at Business Quant, 10x Genomics' Cost of Revenue crashed by 5110.43% in 2021 and then surged by 46366.23% in 2022.
- Quarter analysis of 5 years shows 10x Genomics' Cost of Revenue stood at $27.6 million in 2021, then skyrocketed by 33.44% to $36.8 million in 2022, then skyrocketed by 85.18% to $68.2 million in 2023, then decreased by 20.72% to $54.1 million in 2024, then dropped by 2.0% to $53.0 million in 2025.
- Its Cost of Revenue was $53.0 million in Q4 2025, compared to $48.7 million in Q3 2025 and $47.8 million in Q2 2025.